This year’s Connecticut Veterans Hall of Fame class has a local flair to it.
The Food and Drug Administration (FDA) has cleared Proliv™Rx, an at-home neuromodulation therapy, for use as adjunctive treatment for adults with major depressive disorder (MDD) who have failed to ...
CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...
Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative biostimulation, HA and neuromodulator treatments at the ...
The US MedTech sector is booming with startups transforming healthcare through innovation. The tech ranges from AI ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...
Stanford neuromodulation therapy (SNT), an experimental, accelerated version of magnetic pulse brain stimulation developed at Stanford, may provide a “revolutionary” treatment for severe depression, ...
An estimated 60% of patients with Alzheimer's disease develop epilepsy or subclinical epileptiform activity over the course of the disease. New-onset seizures in cognitively healthy adults also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results